NCT00003230View on ClinicalTrials.gov

Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 1998

Primary Completion Date

July 31, 2000

Study Completion Date

July 31, 2000

Conditions

Leukemia

Interventions

DRUG

paclitaxel

Trial Locations (9)

4500

Burgerspital, Solothurn, Solothurn

5001

Kantonspital Aarau, Aarau

8063

City Hospital Triemli, Zurich

CH 4051

Office of Walter Weber-Stadelman, Basel

CH-4031

University Hospital, Basel

CH-3010

Inselspital, Bern, Bern

CH-1211

Hopital Cantonal Universitaire de Geneva, Geneva

CH-6900

Istituto Oncologico della Svizzera Italiana, Lugano

CH-8008

Klinik Hirslanden, Zurich

All Listed Sponsors

lead

Swiss Cancer Institute

OTHER

NCT00003230 - Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia | Biotech Hunter | Biotech Hunter